Do anticoagulation with heparin and protamine reversal alter thrombogenicity of coated and noncoated pulmonary artery catheters?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 4, 1999, Pages 405-409

  Youngberg, John A ^a   Kaye, Alan D ^a   Anwar, Muhammad ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heparin; Introducers; Primates; Protamine; Pulmonary artery catheters; Thrombus

Indexed keywords

HEPARIN; PROTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTERY CATHETER; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; FEMORAL VEIN; HEMATOCRIT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; PULMONARY ARTERY; RHESUS MONKEY; THROMBOCYTE COUNT; THROMBOGENESIS; THROMBOGENICITY;

EID: 0032867029     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90211-2     Document Type: Article

References (50)

1. Elliott CG, Zimmerman GA, Clemmer TP: Complications of pulmonary artery catheterization in the care of critically ill patients. Chest 76:121-129, 1979
2. Nichols WW, Nichols MA, Barbour H: Complications associated with balloon-tipped, flow-directed catheters. Heart Lung 8:503-506, 1979
3. Damen J: Ventricular arrhythmias during insertion and removal of pulmonary artery catheters. Chest 88:190-193, 1985
4. Patel C, Laboy V, Venus B, et al: Acute complications of pulmonary artery catheter insertion in critically ill patients. Crit Care Med 14:195-197, 1980
5. Sprung CL, Jacobs LJ, Caralis PV, Karpf M: Ventricular arrhythmias during Swan-Ganz catheterization of the critically ill. Chest 79:413-415, 1981
6. Greene JF, Fitzwater JE, Clemmer TP: Septic endocarditis and indwelling pulmonary artery catheters. JAMA 233:891-892, 1975
7. Chastre J, Cornud F, Bouchama A, et al: Thrombosis as a complication of pulmonary artery catheterization via the internal jugular vein. N Engl J Med 306:278-281, 1982
8. Youngberg JA: Pitfalls of invasive monitoring, in Kaplan JA (ed): Cardiothoracic and Vascular Anesthesia Update, vol 3. Philadelphia, PA, Saunders, 1993, pp 1-7
9. Suarez-Penaranda JM, Guitlian B, Concheiro CL: Long-standing intracardiac catheter embolism. An unusual autopsy finding. Am J Forensic Med Pathol 16:124-126, 1995
10. Kinirons B, MacSullivan R: Valve perforation associated with pulmonary catheter insertion. Anaesthesia 51:293, 1996
11. Gosgnach M, Bourel LM, Ducart A, et al: Pulmonary artery catheter balloon: An unusual cause of severe anaphylactic reaction. Anesthesiology 83:220-221, 1995
12. Duong TT, Aldea GS, Connelly GP, et al: Acute pulmonary hypertension after wedging of a pulmonary artery catheter as clues to pulmonary artery perforation. J Cardiothorac Vasc Anesth 7:508-509, 1993
13. Choh JH, Khazei AH, Ihm HJ, et al: Catheter-induced pulmonary arterial perforation during open-heart surgery. J Cardiovasc Surg 35:61-64, 1994
14. Rello J, Jubert P, Esandi ME, Valles J: Specific problems of arterial, Swan-Ganz, and hemodialysis catheters. Nutrition 13:36S-41S, 1997 (suppl)
15. Hoar PF, Stone JG, Wicks AE, et al: Thrombogenesis associated with Swan-Ganz catheters. Anesthesiology 48:445-447, 1974
16. Hoar PF, Wilson RM, Mangano DT, et al: Heparin bonding reduces thrombogenicity of pulmonary artery catheters. N Engl J Med 305:993-995, 1981
17. Doherty PW, Lanteigne D: The in vivo effectiveness of heparin bonding of catheters using idium-111 labeled platelets. Circulation 62:179, 1980 (abstr) (suppl 3)
18. Manson RG, Wolf RH, Zucker WH, Shinoda BA: A nonhuman primate vascular shunt model for thrombus generation. Lab Invest 34:558-564, 1976
19. Koksoy C, Kuzu A, Erden I, Akkaya A: The risk factors in central venous catheter-related thrombosis. Aust NZ J Surg 65:796-798, 1995
20. Rodman NF, Wolf MS, Mason RG: Venous thrombosis on prosthetic surfaces. Am J Pathol 75:229-242, 1974
21. Mollenholt P, Eriksson I, Andersson T: Thrombogenicity of pulmonary artery catheters. Intensive Care Med 13:57-59, 1987
22. Goodman DJ, Rider AK, Billingham ME, Schroeder JS: Thromboembolic complications with the indwelling balloon-tipped pulmonary artery catheter. N Engl J Med 291:777, 1974
23. Yorra FH, Oblath R, Jaffe H, et al: Massive thrombosis associated with the use of Swan-Ganz catheters. Chest 65:682-684, 1974
24. Lowell JA, Bothe A Jr: Central venous catheter-related thrombosis. Urg Oncol Clin N Am 4:479-492, 1995
25. Trottier SJ, Veremakis C, O'Brien J, Auer AI: Femoral deep vein thrombosis associated with central venous catheterization: Results from a prospective, randomized trial. Crit Care Med 23:52-59, 1995
26. Youngberg JA, Texidor M, Wolf R, Therese T: Heparinization and protamine reversal alter thrombogenicity of coated and non-coated pulmonary artery catheters. Anesthesiology 63:A180, 1985
27. Youngberg JA: Aprotinin and thrombus formation on pulmonary artery catheters: A piece of the coagulation puzzle. J Cardiothorac Anesth 14:155-158, 1990
28. Hardhammar PA, van Beusekom HM, Emanuelsson HU, et al: Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93:423-430, 1996
29. Mangano DT: Heparin bonding and long-term protection against thrombogenesis. N Engl J Med 307:894, 1982
30. Monreal M, Alastrue A, Rull M, et al: Upper extremity deep venous thrombosis in cancer patients with venous access devicesprophylaxis with a low-molecular-weight heparin. Thromb Haemost 75:251-253, 1996
31. Nagoaka S, Mikami M, Noishiki Y: Evaluation of antithrombogenic thermodilution catheter. J Biomater Appl 4:22-32, 1989
32. Swan H, Bjoraker D, Emerson C, et al: Heparin-coated pulmonary artery catheters: Clinical and technical considerations. Am Rev Diagn 2:49-55, 1983
33. Youngberg JA, Texidor M, Cantrell C, et al: Introducers and protective sleeves increase thrombogenicity of pulmonary artery catheters. Anesthesiology 63:A181, 1985
34. Snedecor GW, Cochran WG: Statistical Methods (ed 6). Ames, IA, The Iowa State University Press, 1967
35. Breddin HK: Pathophysiology of thromboembolism and its modulation by low-molecular-weight heparins. Semin Thromb Hemost 22:25-27, 1996 (suppl 1)
36. Simonneau G, Sors H, Charbonnier B, et al: A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med 337:663-669, 1997
37. Palmer AJ, Schramm W, Kirchhof B, Bergemann R: Lowmolecular-weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: A meta-analysis of randomised clinical trials. Haemostasis 27:65-74, 1997
38. Engbers GH, Dost L, Hennink WE, et al: An in vitro study of the adhesion of blood platelets onto vascular catheters. Part I. J Biomed Mater Res 21:613-627, 1987
39. Ernofsson M, Thelin S, Siegbahn A: Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits. Scand J Thorac Cardiovasc Surg 29:157-165, 1995
40. Raskob GE: Low-molecular-weight heparin for the prevention and treatment of venous thromboembolism. Curr Opin Pulm Med 2:305-310, 1996
41. Dye L, Segall P, Russel R, et al: Deep venous thrombosis of the upper extremity associated with use of the Swan-Ganz catheter. Chest 73:673-675, 1978
42. Kim SW, Jacobs H: Design of nonthrombogenic polymer surfaces for blood-contacting medical devices. Blood Purif 14:357-372, 1996
43. Amljots B, Wieslander JB, Dougan P, Salemark L: Importance of fibrinolysis in limiting thrombus formation following severe microarterial trauma: An experimental study in the rabbit. Microsurgery 12:332-339, 1991
44. Lindoff C, Rybo G, Astedt B: Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70:238-240, 1993
45. Royston D: Aprotinin in patients having coronary artery bypass graft surgery. Curr Opin Cardiol 10:591-596, 1995
46. Zhang B, Wieslander JB: Influence of early fibrinolysis inhibition on thrombus formation following microvascular trauma. Microsurgery 17:278-285, 1996
47. Hardy JF, Desroches J: Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 39:353-365, 1992
48. Horrow JC, Hlavacek J, Strong MD, et al: Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 99:70-74, 2990
49. Jordan D, Delphin E, Rose E: Prophlactic epsilon-aminocaproic acid (EACA) administration minimizes blood replacement therapy during cardiac surgery. Anesth Analg 80:827-829, 1995
50. Cosgrove DM III, Heric B, Lytle BW, et al: Aprotonin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 54:1031-1036, 1992